This medication is an anti-cancer drug, prescribed for certain types of cancers like multiple myeloma, brain tumor, Hodgkin’s and non – Hodgkin’s lymphoma. The medication restricts the advancement of the cancer cell growth in the body.
IV- The recommended dose as a single agent in previously untreated patients is 150 to 200 mg/m² intravenously every 6 weeks. This may be given as a single dose or divided into daily injections such as 75 to 100 mg/m² on 2 successive days.
It comes as a solution for injection, administered by healthcare providers.
• Avoid immunization while taking this medication.
• If you are taking any other medication, inform the doctor.
• Caution should be exercised in patients with history of liver or kidney impairment, decrease in blood count, bone marrow depression, lung disease, during pregnancy and breast-feeding.
• Monitor blood count, liver, kidney and lung function regularly while taking this medication.
• It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication.
• Body as whole:
Fever, chills, sore throat, loss of appetite or weight and swelling in ankle and feet region.
• Skin : Pale skin, easy bruising and redness.
• Blood: Abnormal bleeding.
• Heart : Rapid heart beat.
• Respiratory : Wheezing and chest pain.
• Gastrointestinal: Nausea, vomiting and diarrhea.
• Central Nervous System: Confusion, headache, weakness, dizziness, drowsiness and mood changes.
• Eye : Vision imbalance.
• Delayed effect: Liver and kidney damage, lung fibrosis and stomach upset.
• Potentially Fatal: Delayed and cumulative bone marrow depression.
Avoid alcohol consumption while taking this medication.
Store in refrigerator at 2-8°C; away from light.
Subscribe to our Free Newsletters!